A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination

BACKGROUND: Recombinant protein subunit vaccination is considered to be a safe, fast and reliable technique when combating emerging and re-emerging diseases such as coronavirus disease 2019 (COVID-19). Typically, such subunit vaccines require the addition of adjuvants to attain adequate immunogenici...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhidong, Chen, Jian-Ping, Xu, Jin-Chuan, Chen, Zhen-Yan, Qu, Rong, Zhang, Ling, Yao, Wenrong, Wu, Juan, Yang, Heng, Lowrie, Douglas B., Liu, Yong, Fan, Xiao-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634073/
https://www.ncbi.nlm.nih.gov/pubmed/34864488
http://dx.doi.org/10.1016/j.virol.2021.11.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634073/
https://www.ncbi.nlm.nih.gov/pubmed/34864488
http://dx.doi.org/10.1016/j.virol.2021.11.011

Ejemplares similares